Laos vs Libya: Share of pregnant women with HIV that receive antiretroviral therapy
Laos
68.0%
in 2024
Libya
70.0%
in 2023
Laos rank
54th
Libya rank
51st
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Laos
- Libya
How they compare
Libya currently reports 70.0% against 68.0% in Laos, a difference of 2.0%.
The two have swapped places 2 times across 18 shared years of data; in 2000 it was Libya ahead.
Laos ranks 54th and Libya ranks 51st of 84 countries.
Across the 3 decades both report, Laos averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Laos | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.2% | 0.0% | 4.2% | Laos |
| 2010s | 28.0% | 65.8% | 37.8% | Libya |
| 2020s | 39.0% | 71.0% | 32.0% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Laos or Libya?
- Libya, at 70.0% against 68.0% in Laos as of 2023.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Laos and Libya?
- 2.0%, with Libya ahead.
- How many years of comparable data are there for Laos and Libya?
- 18 years are reported by both, from 2000 to 2023.
- How do Laos and Libya rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Laos ranks 54th and Libya ranks 51st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.